Cis-dichlorodiammineplatinum (II) : a new antitumor agent
Rainey, J.M.
Arizona Medicine 35(7): 462-463
1978
ISSN/ISBN: 0004-1556 PMID: 678146 Document Number: 136692
Document emailed within 1 workday
Related Documents
Takahashi, K.; Nishikawa, K.; Kita, M.; Nakayama, Y.; Sakakibara, T.; Ito, K.; Tsubosaki, M.; Konoha, N. 1982: Antitumor activity and toxicity of the degradation products and the aquated species of cis-dichlorodiammineplatinum (II) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(4): 616-623Pera, M.F.; Harder, H.C. 1979: Effects of mannitol or furosemide diuresis on cis-dichlorodiammineplatinum(II) antitumor activity and toxicity to host-renewing cell populations in rats Cancer Research 39(4): 1279-1286
Lee, S.H.; Chiu, H.; Rinderknecht, E.; Sabo, W.; Stebbing, N. 1983: Importance of treatment regimen of interferon as an antitumor agent Cancer Research 43(9): 4172-4175
Banovic, P.; Stankov, S.; Vranjes, N.; Zurkovic, O.; Capo, I.; Lalosevic, D. 2018: Drug repurposing: mebendazole as effective antitumor agent. Are we seeing the whole story? Journal of BUON: Official Journal of the Balkan Union of Oncology 23(6): 1904-1911
Wampler, G.L.; Kuperminc, M.; Regelson, W. 1973: Phase i study of tilorone, a non-marrow depressing antitumor agent Cancer ChemoTherapy Reports 57(2): 209-217
Tiagotin, I.V.; Polotskiĭ, A.E.; Vakhitov, T.I.; Tutova, I.I.; Rybakova, L.P. 1998: Experimental study of the biopreparation Lymphotilin as an antiproliferative and antitumor agent Voprosy Onkologii 44(1): 92-96
McGovren, J.P.; Neil, G.L.; Denlinger, R.H.; Hall, T.L.; Crampton, S.L.; Swenberg, J.A. 1979: Chronic cardiotoxicity studies in rabbits with 7-con-O-methylnogarol, a new anthracycline antitumor agent Cancer Research 39(12): 4849-4855
Li, L.H.; Swenson, D.H.; Schpok, S.L.; Kuentzel, S.L.; Dayton, B.D.; Krueger, W.C. 1982: CC-1065 (NSC 298223), a novel antitumor agent that interacts strongly with double-stranded DNA Cancer Research 42(3): 999-1004
Friedman, J.; Moore, E.C.; Hall, S.W.; Loo, T.L. 1979: Enzymatic assay for the antitumor agent-N-(phosphonacetyl)-L-aspartic acid (PALA) Cancer Treatment Reports 63(1): 85-88
Sur, P.; Bag, S.P.; Sur, B.; Khanam, J.A. 1997: Chloroaceto hydroxamic acid as antitumor agent against Ehrlich ascites carcinoma in mice Neoplasma 44(3): 197-201
Fukuda, M.; Arimura, T.; Katayama, K.; Watanabe, H. 1991: Complete response provided by new antitumor agent, MST-16 (sobuzoxane), in a breast cancer with multiple cutaneous metastases Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(10): 1709-1712
Wodinsky, I.; Swiniarski, J.K. 1975: Antitumor activity of amygdalin MF (NSC-15780) as a single agent and with beta-glucosidase (NSC-128056) on a spectrum of transplantable rodent tumors Cancer ChemoTherapy Reports 59(5): 939-950
Tsuruo, T.; Oh-hara, T.; Iida, H.; Tsukagoshi, S.; Sato, Z.; Matsuda, I.; Iwasaki, S.; Okuda, S.; Shimizu, F.; Sasagawa, K. 1986: Rhizoxin, a macrocyclic lactone antibiotic, as a new antitumor agent against human and murine tumor cells and their vincristine-resistant sublines Cancer Research 46(1): 381-385
Gliniak, B.; Le, T. 1999: Tumor necrosis factor-related apoptosis-inducing ligand's antitumor activity in vivo is enhanced by the chemotherapeutic agent CPT-11 Cancer Research 59(24): 6153-6158
Honn, K.V.; Meyer, J.; Neagos, G.; Henderson, T.; Westley, C.; Ratanatharathorn, V. 1982: Control of tumor growth and metastasis with prostacyclin and thromboxane synthetase inhibitors: evidence for a new antitumor and antimetastatic agent (BAY g 6575) Progress in Clinical and Biological Research 89: 295-331
Neil, G.L.; Berger, A.E.; McPartland, R.P.; Grindey, G.B.; Bloch, A. 1979: Biochemical and pharmacological effects of the fermentation-derived antitumor agent, (alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125) Cancer Research 39(3): 852-856
Baraldi, P.G.; Cacciari, B.; Guiotto, A.; Romagnoli, R.; Spalluto, G.; Zaid, A.N.; Capolongo, L.; Cozzi, P.; Geroni, C.; Mongelli, N. 1997: Synthesis, solvolytic stability and cytotoxicity of a modified derivative of CPzI, a pyrazole analog of the alkylation subunit of the antitumor agent CC-1065: effect of the nitrogen substitution on the functional reactivity Farmaco 52(12): 717-723
Ebina, T.; Shishido, K.; Murata, K. 1990: Antitumor effect of a novel antitumor compound, NC-190, in the double grafted tumor system Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(7): 1345-1350
Hrabowska, M.; Ledóchowski, A.; Stefańska, B.; Onoszko, K. 1970: A search for antitumor compounds. 8. Biologic studies. Antitumor properties of 17 new 1-nitro-9-aminoacridine derivatives Archivum Immunologiae et Therapiae Experimentalis 18(5): 557-570
Hosokawa, M.; Morikawa, K. 1984: Augmentation of antitumor immune responses by the antitumor antibiotic bleomycin Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(12 Part 2): 2700-2708